Therapeutic antibody developer Patrys names new CEO
Therapeutic antibody developer Patrys (ASX:PAB) appointed Dr. Samantha South as its new CEO, effective Feb. 16.
Therapeutic antibody developer Patrys (ASX:PAB) appointed Dr. Samantha South as its new CEO, effective Feb. 16.
The Australian Prudential Regulation Authority has reined in four unnamed banks for breaching new "guardrails" designed to limit high-risk mortgage lending.
Technology services provider EROAD (ASX:ERD) announced that CEO Mark Heine will resign in June.
US lithium giant Albemarle has announced the immediate mothballing of its final remaining refinery operations at Kemerton in Western Australia.
American Uranium (ASX:AMU) has commenced its 2026 resource development drilling program at the Lo Herma ISR Uranium Project.
Marmota (ASX:MEU) has secured firm commitments to raise $15 million through a single-tranche placement.
RBA Governor Michele Bullock addresses Australia's productivity slowdown, the impact of public sector growth in healthcare, and the independence of the monetary policy board.
Lendlease Group (ASX:LLC) announced that Group CEO and Managing Director Tony Lombardo will step down in August.
Peel Mining (ASX:PEX) announced a binding agreement to be acquired by Aeris Resources (ASX:AIS) via a scheme of arrangement.
Paladin Energy (ASX:PDN) reported a robust revenue of US$138.3 million in H1 FY26, underpinned by the sale of 1.96Mlb of triuranium octoxide at an average realised price of US$70.5/lb.
Breville Group (ASX:BRG) has unveiled a landmark set of financial results for the half-year ended Dec. 31, 2025, surpassing the billion-dollar milestone with record revenues of $1.19 billion.
Pro Medicus (ASX:PME) announced a first-half revenue increase of 28.4% to $124.8 million, while underlying profit before tax rose nearly 30% to $90.7 million.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade